Radiogenomic Analysis Demonstrates Associations between¹⁸F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non–Small Cell Lung Cancer

Abstract

Purpose To investigate whether non-small cell lung cancer (NSCLC) tumors that express high normalized maximum standardized uptake value (SUVmax) are associated with a more epithelial-mesenchymal transition (EMT)-like phenotype. Materials and Methods In this institutional review board-approved study, a public NSCLC data set that contained fluorine 18 ((18)F) fluoro-2-deoxyglucose positron emission tomography (PET) and messenger RNA expression profile data (n = 26) was obtained, and patients were categorized on the basis of measured normalized SUVmax values. Significance analysis of microarrays was then used to create a radiogenomic signature. The prognostic ability of this signature was assessed in a second independent data set that consisted of clinical and messenger RNA expression data (n = 166). Signature concordance with EMT was evaluated by means of validation in a publicly available cell line data set. Finally, by establishing an in vitro EMT lung cancer cell line model, an attempt was made to substantiate the radiogenomic signature with quantitative polymerase chain reaction, and functional assays were performed, including Western blot, cell migration, glucose transporter, and hexokinase assays (paired t test), as well as pharmacologic assays against chemotherapeutic agents (half-maximal effective concentration). Results Differential expression analysis yielded a 14-gene radiogenomic signature (P < .05, false discovery rate [FDR] < 0.20), which was confirmed to have differences in disease-specific survival (log-rank test, P = .01). This signature also significantly overlapped with published EMT cell line gene expression data (P < .05, FDR < 0.20). Finally, an EMT cell line model was established, and cells that had undergone EMT differentially expressed this signature and had significantly different EMT protein expression (P < .05, FDR < 0.20), cell migration, glucose uptake, and hexokinase activity (paired t test, P < .05). Cells that had undergone EMT also had enhanced chemotherapeutic resistance, with a higher half-maximal effective concentration than that of cells that had not undergone EMT (P < .05). Conclusion Integrative radiogenomic analysis demonstrates an association between increased normalized (18)F fluoro-2-deoxyglucose PET SUVmax, outcome, and EMT in NSCLC. (©) RSNA, 2016 Online supplemental material is available for this article.

Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer

“…These results shed important light on the underlying biology behind prognostic imaging markers, which may ultimately inform prevention and treatment strategies. maximum standardized uptake value at fluorine 18 fluorodeoxyglucose positron emission tomography in non-small cell lung cancer (68). A second distinction is that prior radiogenomic studies have focused image analysis on the tumor, while we specifically analyzed the tumoradjacent parenchymal tissue.…”

Diffusion kurtosis imaging evaluating epithelial–mesenchymal transition in colorectal carcinoma xenografts model: a preliminary study

“…In the present study, EMT model was induced in HCT116 CRC cell line by overexpressing the EMT regulator Snail1. The EMT model is a well-established model in the previous studies 17 , 18 , where EMT model can be induced by transforming growth factor β (TGF-β) or EMT regulators overexpression. Several transcription factors including Snail1, ZEB1, Twist, and so on have been implicated in the control of EMT, Snail1 has been reported as a central mediator of EMT among the factors and plays a role in aggravating the invasiveness and metastatic behavior of malignant neoplasms 4 , 19 – 22 .…”

“…Recently, machine learning-based approaches including radiomics, radiogenomics, and so on, have drawn more and more attention and demonstrated the potential feasibility in lesion detection and classification, including but are not limited to prostate cancer, bladder cancer, glioblastoma, and non-small cell lung cancer (NSCLC) 18 , 33 – 35 . Radiogenomics referring to the combination of imaging and gene expression is reported to have the potential to give insight into tumor biology.…”

RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment

“… 2 The main reason behind the dismal survival statistics is that most lung cancer patients are terminally ill and cannot be cured with existing therapies. 3 As far as we know, there is little information about quercetin (QCT) regulating the ultrastructural changes of lung cancer.…”